Up-and-coming researchers, technologists, and entrepreneurs convene at MIT to celebrate their achievements and reaffirm their hopes for the future.
How a Greek doctor accidentally discovered one of the most effective cancer-screening tests.
The convergence of biology with computing and nanotechnology is yielding safer and more effective medicines.
Customers want the opportunity to convince themselves that new products are indispensable.
European countries are imposing a patchwork of tough restrictions that are impeding research.
Hoping to squeeze more products out of a sputtering drug pipeline, pharmaceutical makers are Aiming to exploit advances in molecular biology. That means changing everything from their corporate cultures to the nature of their university collaborations.
GE's Jeffrey Immelt sees high-tech firms dominating a slow-growth economy-and the biggest players becoming the biggest winners.
Some people are saddled with names they hate. But thanks to a new twist on a familiar technology, today's parents can avoid ghastly mistakes.
Comic strips for a quarter? A new twist on micropayments is raising the likelihood that you'll be able to pay tiny sums of money for small slivers of information.
Insights and opinions from our readers.